Lyra Therapeutics, Inc. (LYRA)
1.89
0.00 (0.00%)
USD |
NASDAQ |
Jan 15, 11:52
Lyra Therapeutics EPS Diluted (Quarterly): -3.385 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Dentsply Sirona, Inc. | -2.140 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Electromed, Inc. | 0.246 |
| InfuSystem Holdings, Inc. | 0.1078 |
| Xtant Medical Holdings, Inc. | 0.0087 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.984M |
| Revenue (Quarterly) | 0.025M |
| Total Expenses (Quarterly) | 6.009M |
| Enterprise Value | 11.83M |
| Gross Profit Margin (Quarterly) | -300.0% |
| Profit Margin (Quarterly) | -23.94K% |
| Earnings Yield | -921.1% |
| Normalized Earnings Yield | -863.68 |